Dr. Reddy’s Labs Signs Licensing Pact With Gilead for Remdesivir

(Bloomberg) -- Dr. Reddy’s Laboratories Ltd. entered into a non-exclusive licensing agreement with Gilead Sciences Inc. giving it the right to register, manufacture and sell Remdesivir, which is be...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.